perfosfamide has been researched along with Genetic Predisposition in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antao, N; Cohn, SL; Cox, NJ; Diskin, SJ; Dolan, ME; Gamazon, ER; Im, HK; Konkashbaev, A; London, WB; Ludeman, SM; Maris, JM; Myers, J; Pinto, N; Stark, AL | 1 |
1 other study(ies) available for perfosfamide and Genetic Predisposition
Article | Year |
---|---|
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Child; Cohort Studies; Cyclohexylamines; Cyclophosphamide; Disease-Free Survival; Drug Resistance, Neoplasm; Genetic Predisposition to Disease; Genetic Variation; Genome-Wide Association Study; Humans; Neuroblastoma; Phenotype; Polymorphism, Single Nucleotide; Quality Control; Real-Time Polymerase Chain Reaction; Risk Assessment; RNA, Small Interfering; Treatment Failure | 2014 |